Changes within the DMN have been observed in healthy aging [22], [94], [95], Alzheimer’s disease [34], [95], [96], individuals with amnestic mild cognitive impairment [97], and in APOE-ε4 carriers [98], [99]. This evidence concerns the gene APOE and Cognitive impairment.